Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy Trial

  • Kenneth G. Saag*
  • , Nicola Pannacciulli
  • , Piet Geusens
  • , Jonathan D. Adachi
  • , Osvaldo D. Messina
  • , Jorge Morales-Torres
  • , Ronald Emkey
  • , Peter W. Butler
  • , Xiang Yin
  • , Willem F. Lems
    • *Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy Trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

INIS

Pharmacology, Toxicology and Pharmaceutical Science